Results 141 to 150 of about 36,883 (260)

Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024

Addiction, EarlyView.
Abstract Background and aims Nitazenes are a novel subclass of synthetic opioids that have been increasingly implicated in the United States (US) overdose crisis. Despite their growing presence in the illicit drug supply, national trends have not been systematically evaluated.
David T. Zhu, Nicole D. Fitzgerald, Joseph J. Palamar, Alex J. Krotulski   +3 more
wiley   +1 more source

A Scoping Review of Youth Overdose Prevention Interventions. [PDF]

J Addict Med
Renehan CM, Wiggins M, Puppala R, Chatterjee A, Obando A, Coleman KR, Raj A, Schmill DM, Flynn D, Bagley SM.   +9 more
europepmc   +1 more source

Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series

Addiction, EarlyView.
Abstract Background and aims Evidence regarding the impacts of supervised drug consumption services (SDC) remains mixed, and few evaluations have used individual‐level, linkable health data to examine service withdrawal. In September 2024, the Red Deer overdose prevention site (OPS) in Alberta, Canada, was scheduled for closure, with operations ceasing
Nathaniel Day, Kym Kaufmann, Daniel John Alexander Devoe, Vanja Grubac, Alessia DiMarzo, Haisa Osmanli, Vanessa Norton, Shelly Vik, Nickie Mathew, Robert Lawrence Tanguay, Anees Bahji   +10 more
wiley   +1 more source

Overdose Prevention Centers and Neighborhood Commercial Activity in New York City.

JAMA Netw Open
Allen B, Basaraba C, Chambers LC, Behrends CN, Marshall BDL, Cerdá M.   +5 more
europepmc   +1 more source

Strategies to Facilitate Interorganizational Collaboration in County-Level Opioid Overdose Prevention and Response: A Qualitative Analysis. [PDF]

Int J Environ Res Public Health
Dickson-Gomez J, Krechel S, Ohlrich J, Hernandez-Meier J, Kostelac C.   +4 more
europepmc   +1 more source

Regional perspectives: Substance use related problems in Ethiopia

Addiction, EarlyView.
Abstract Ethiopia, with a population exceeding 130 million, presents a complex landscape for understanding substance use disorders. The country's diverse cultural heritage, varying regional practices, and evolving socioeconomic conditions create unique factors of substance use that differ markedly from global trends.
Tesfa M. Yimer, Wubalem Fekadu, Janni Leung, Awoke Mihretu, Solomon Teferra   +4 more
wiley   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source

Health, Costs, and Injection-Related Infections at a Hypothetical Overdose Prevention Center.

JAMA Netw Open
Padmanabhan P, Tin Y, Nall SK, Al-Tayyib A, Yoder T, Yamkovoy K, Fotso K, Christine PJ, Jurecka C, Raville L, Kline DM, Barocas JA.   +11 more
europepmc   +1 more source

Assessing User Engagement With an Interactive Mapping Dashboard for Overdose Prevention Informed by Predictive Modeling in Rhode Island. [PDF]

J Public Health Manag Pract
Skinner A, Neill DB, Allen B, Krieger M, Gray JY, Pratty C, Macmadu A, Goedel WC, Samuels EA, Samuels EA, Ahern J, Cerdá M, Marshall BDL.   +12 more
europepmc   +1 more source

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

Addiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski, Jason M. Nagata, Suzanne Nielsen   +2 more
wiley   +1 more source